IT8620208A0 - Eteri del 7-ossabicicloeptano sostituiti quali analoghi di prostaglandine e relative composizioni farmaceutiche. - Google Patents

Eteri del 7-ossabicicloeptano sostituiti quali analoghi di prostaglandine e relative composizioni farmaceutiche.

Info

Publication number
IT8620208A0
IT8620208A0 IT8620208A IT2020886A IT8620208A0 IT 8620208 A0 IT8620208 A0 IT 8620208A0 IT 8620208 A IT8620208 A IT 8620208A IT 2020886 A IT2020886 A IT 2020886A IT 8620208 A0 IT8620208 A0 IT 8620208A0
Authority
IT
Italy
Prior art keywords
oxabicichloheptanethers
substituted
pharmaceutical compositions
prostaglandin analogues
related pharmaceutical
Prior art date
Application number
IT8620208A
Other languages
English (en)
Other versions
IT1189091B (it
IT8620208A1 (it
Inventor
Steven E Hall
Wen-Ching Han
Original Assignee
Squibb & Sons Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Squibb & Sons Inc filed Critical Squibb & Sons Inc
Publication of IT8620208A0 publication Critical patent/IT8620208A0/it
Publication of IT8620208A1 publication Critical patent/IT8620208A1/it
Application granted granted Critical
Publication of IT1189091B publication Critical patent/IT1189091B/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Obesity (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
IT20208/86A 1985-04-26 1986-04-24 Eteri del 7-ossabicicloeptano sostituiti quali analoghi di composizioni farmaceutiche IT1189091B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/727,965 US4608386A (en) 1985-04-26 1985-04-26 7-oxabicycloheptane ethers useful in the treatment of thrombotic diseases

Publications (3)

Publication Number Publication Date
IT8620208A0 true IT8620208A0 (it) 1986-04-24
IT8620208A1 IT8620208A1 (it) 1987-10-24
IT1189091B IT1189091B (it) 1988-01-28

Family

ID=24924854

Family Applications (1)

Application Number Title Priority Date Filing Date
IT20208/86A IT1189091B (it) 1985-04-26 1986-04-24 Eteri del 7-ossabicicloeptano sostituiti quali analoghi di composizioni farmaceutiche

Country Status (7)

Country Link
US (1) US4608386A (it)
JP (1) JPS61257988A (it)
CA (1) CA1249290A (it)
DE (1) DE3613719A1 (it)
FR (1) FR2581066B1 (it)
GB (1) GB2174394B (it)
IT (1) IT1189091B (it)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001506970A (ja) * 1996-09-06 2001-05-29 イーライ・リリー・アンド・カンパニー 方法及び新規な中間体
AU2002322720B2 (en) 2001-07-25 2008-11-13 Raptor Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
DE10164594A1 (de) 2001-12-21 2003-07-03 Bellheimer Metallwerk Gmbh Umlauf-Lagersystem
JP4766856B2 (ja) * 2004-08-31 2011-09-07 ダイセル化学工業株式会社 酸素原子含有多環式化合物、重合性組成物及びその硬化物
CN102379684B (zh) 2005-04-28 2014-11-19 普罗透斯数字保健公司 药物信息系统
KR20090071598A (ko) 2006-09-18 2009-07-01 랩터 파마슈티컬 인코포레이티드 수용체 결합 단백질(ｒａｐ)-접합체 투여에 의한 간 질환의 치료
EP2398500B1 (en) 2009-02-20 2019-03-13 2-BBB Medicines B.V. Glutathione-based drug delivery system
ES2942923T3 (es) 2009-05-06 2023-06-07 Laboratory Skin Care Inc Composiciones de administración dérmica que comprenden complejos de agente activo-partículas de fosfato de calcio y métodos de uso de las mismas
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4187236A (en) * 1977-11-04 1980-02-05 E. R. Squibb & Sons, Inc. 7-Oxabicycloheptane compounds
US4220594A (en) * 1977-11-04 1980-09-02 E. R. Squibb & Sons, Inc. Hexa- and octahydro-4,7-epoxyisobenzofuran-1-ol and hexa- and octahydro-5,8-epoxy-1H-2-benzopyran-3-ol
US4254044A (en) * 1977-11-04 1981-03-03 E. R. Squibb & Sons, Inc. 7-Oxabicycloheptane- and 7-oxabicycloheptene compounds
US4143054A (en) * 1977-11-04 1979-03-06 E. R. Squibb & Sons, Inc. 7-oxabicycloheptane- and 7-oxabicycloheptene compounds
EP0045118B1 (en) * 1979-01-05 1984-04-04 National Research Development Corporation Intermediates for the synthesis of bicyclo (2,2,1) heptanes and bicyclo (2,2,1) hept-2z-enes
US4228180A (en) * 1979-11-01 1980-10-14 E. R. Squibb & Sons, Inc. 7-Oxabicycloheptane and 7-oxabicycloheptene prostaglandin analogs
ZA814307B (en) * 1980-07-01 1983-02-23 Nat Res Dev Prostaglandins
US4416896A (en) * 1982-05-17 1983-11-22 E. R. Squibb & Sons, Inc. 7-Oxabicyclopheptane substituted amino prostaglandin analogs useful in the treatment of thrombolytic disease
US4474803A (en) * 1983-03-14 1984-10-02 E. R. Squibb & Sons, Inc. 7-Oxabicycloheptane substituted thio prostaglandin analogs useful in treating platelet aggregation and bronchoconstriction
CA1256887A (en) * 1983-03-14 1989-07-04 Steven E. Hall 7-oxabicycloheptane substituted prostaglandin analogs

Also Published As

Publication number Publication date
DE3613719A1 (de) 1986-10-30
FR2581066A1 (fr) 1986-10-31
JPS61257988A (ja) 1986-11-15
GB8610058D0 (en) 1986-05-29
IT1189091B (it) 1988-01-28
GB2174394B (en) 1988-11-30
GB2174394A (en) 1986-11-05
CA1249290A (en) 1989-01-24
IT8620208A1 (it) 1987-10-24
FR2581066B1 (fr) 1989-02-24
US4608386A (en) 1986-08-26

Similar Documents

Publication Publication Date Title
IT7928417A0 (it) Composizioni farmaceutiche con esaltazione dell'attivita'terapeutica di cortisonici.
FI872733L (fi) Farmaceutiska kompositioner.
IT8621342A0 (it) Analoghi di ammide-tioammide prostaglandina 7 ossabicicloeptano sostituiti.
DE3682083D1 (de) Pharmazeutische zusammensetzungen.
FI872313A7 (fi) Farmaseuttisia ainekoostumuksia.
IT8622844A0 (it) Formulazioni farmaceutiche acquose di ubichinone.
FI863435A7 (fi) Maun peittäviä koostumuksia.
FI883673A7 (fi) Farmaceutiska kompositioner.
IT1213453B (it) Composizione farmaceutica.
DE3674040D1 (de) Pharmazeutische zusammensetzungen.
IT1211967B (it) Composizione farmaceutica contenente ranitidina
IT1200099B (it) Composizioni farmaceutiche somministrabili per via nasale
DE3689646D1 (de) Antiseptische zusammensetzungen.
IT8620208A1 (it) Eteri del 7-ossabicicloeptano sostituiti quali analoghi di prostaglandine e relative composizioni farmaceutiche
IT8619526A0 (it) Analoghi di prostaglandina 7-ossabicicloeptano sostituiti.
IT8019486A0 (it) Analoghi delle prostaglandine.
IT8619456A0 (it) Analoghi di prostaglandine sostituiti con tiabicicloeptano avenyi attivita' cardiovascolare.
IT8620163A0 (it) Analoghi di prostaglandine 7-ossabicicloeptano sostituiti.
IT8619557A0 (it) Analoghi di ammino prostaglandine tiabicicloeptano-sostituite.
NO168176C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive, substituerte benzamider
IT7822316A0 (it) Composizione farmaceutica per la somministrazione di pancreatina.
IT8520384A0 (it) Procedimento per la produzione di chlorothalonil avente idonea struttura cristallografica.
IT1203737B (it) Composizioni farmaceutiche comprendenti 3-amminopropossi-indoli
IT8721457A0 (it) Composizioni farmaceutiche antivirali.
IT1215261B (it) Composizioni farmaceutiche adattivita' antigalattopoietica.